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BACKGROUND: Sindbis virus (SIN) infection causes no or only mild symptoms (fever, rash, and arthralgia) in humans. However, SIN has
a strong cytopathic effect (CPE) on various cancer cells. This study focuses on the oncolytic activity of SIN AR399 on oral cancer cells
compared with reovirus, a well-known oncolytic virus that targets cancer cells.
METHODS: We analysed the cytotoxicity and growth of SIN in 13 oral squamous cell carcinoma (OSCC) cell lines (HSC-2, HSC-3,
HSC-4, Ca9-22, H-1, Sa-3, KON, KOSC-2, OK-92, HO-1-N1, SCC-4, SAT, SKN-3) and normal human oral keratinocytes (NHOKs).
RESULTS: Sindbis virus infection induced CPE in 12 OSCC cell lines at a low multiplicity of infection (MOI) of 0.01, but not in the OSCC
cell line, HSC-4 or NHOKs. Sindbis viral growth was not observed in NHOKs, whereas high SIN growth was observed in all OSCC
cell lines, including HCS-4. The cytotoxicity and growth of SIN was the same as reovirus at an MOI of 20 in 12 OSCC cell lines. The
CPE was shown, by terminal deoxyribonucleotidyl transferase–mediated dUTP nick-end labelling assays, to be apoptotic cell death.
Furthermore, quantitative RT-PCR of mRNA in HSC-3 and HSC-4 cells after SIN infection showed that activation of caspases,
cytochrome c, and IkBa was associated with SIN-induced apoptosis.
CONCLUSION: As a replication-competent oncolytic virus, SIN may be a useful therapeutic modality for oral cancers.
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Squamous cell carcinoma (SCC) is the sixth most common cancer in
the world and a major cause of morbidity (Parkin et al, 1999; Hunter
et al, 2005). Treatment of oral SCC (OSCC) has primarily relied on
classical therapeutic modalities including surgery, radiation, and
chemotherapy or a combination of these methods; yet, the outcome
of OSCC has not improved significantly. Therefore, new treatment
strategies are of interest, especially gene therapy. Several gene
therapy strategies for OSCC are currently under investigation in the
preclinical and clinical settings (Kim et al, 2002; Xi and Grandis,
2003). Replication-defective viruses are used as vectors for cancer
gene therapy. Several viral vector systems, such as those encoding
suicide proteins, tumour suppressor proteins, or cytokines are used
to introduce various genes into tumour cells. However, the
efficiency of this approach is limited because vectors transduce
these genes into only a small portion of the target cells. Therefore,
replication-competent viruses that target cancer cells have also been
studied as anti-cancer agents (Parkin et al, 1999; Xi and Grandis,
2003; Hunter et al, 2005).
S i n d b i sv i r u s( S I N )i sa nR N Av i r u sb e l o n g i n gt ot h eAlphavirus
genus in the Togaviridae virus family; it is transmitted to birds and
mammals by mosquito bites (Jan and Griffin, 1999) and subse-
quently spreads throughout the body through the bloodstream
(Tseng et al, 2002; Unno et al, 2005). It has the potential to induce
apoptosis of infected mammalian cells (Jan and Griffin, 1999;
Moriishi et al, 2002). In addition, one of the surface receptors on
mammalian cells mediating SIN infection has been identified as the
67-kDa, high-affinity laminin receptor (Wang et al,1 9 9 2 ) ,r e p o r t e d
to be highly expressed in various human cancers (van den Brule
et al, 1996). Sindbis virus infection induces no or only mild
symptoms (fever, rash, and arthralgia) in humans (Jan and Griffin,
1999). Several replication-defective SIN vector systems have been
studied for in vitro gene transfer into mammalian cells and in vivo
gene therapy (Tseng et al, 2002; Yamanaka, 2004; Unno et al, 2005).
However, whether replication-competent wild-type SIN can be used
as an anti-cancer agent in oral cancers has not been investigated.
In this study, we tested 13 OSCC cell lines, as well as normal
human oral keratinocytes (NHOKs), for susceptibility to SIN
infection in vitro. For comparison, cell lines were also infected with
reovirus, a well-known oncolytic virus with Ras pathway activation
(Hirasawa et al, 2002). We also evaluated the expression of genes
involved in apoptosis after SIN infection.
MATERIAL AND METHODS
Cell lines and cell culture
The OSCC-derived cell lines HSC-2, HSC-3, HSC-4, SCC-4, SAT,
Ca9-22, SKN-3, KON, HO-1-N1, KOSC-2 (Human Science Research
Resources Bank, Osaka, Japan), OK-92 (established from a
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scarcinoma of the tongue in our department), Sa-3, and H-1
(provided by Dr Shigeyuki Fujita, Wakayama Medical University,
Wakayama, Japan) were grown in Dulbecco’s modified Eagle’s
medium (DMEM) with 10% fetal bovine serum (FBS) and 50 units
per ml of penicillin and streptomycin. Laboratory stock Vero cells
were maintained in DMEM supplemented with 10% FBS at 371Ci n
5% CO2. Primary cultured NHOKs were grown in KGM.
Viruses
The SIN AR339 (wild-type) virus used in this study was provided
by the National Institute of Infectious Diseases (Tokyo, Japan).
The virus was propagated in primary chicken embryo fibroblast
cells, then passed several times in Vero cells and used as a
laboratory stock. AR339 was propagated in C33A cells maintained
in DMEM supplemented with 10% FBS at 371Ci n5 %C O 2. Viral
titres were determined by plaque assays using monolayers of
Vero cells. The laboratory stock reovirus strain T3D used in this
study was propagated in L cells (ATCC, Manassas, VA, USA),
and viral titres were determined by plaque assays using mono-
layers of L cells.
Cytotoxicity of viruses in cell lines
Cells were plated onto 24-well plates at 1 10
5 cells per well
and infected with SIN at a multiplicity of infection (MOI) of 20, 1,
0.1, or 0.01, or reovirus at an MOI of 20. After incubation for 96h,
cell viability was evaluated and the medium was removed. Each
plate was equilibrated to room temperature (about 251C) for
20min, followed by addition of 200ml of CellTiter Glo reagent
(Promega, Madison, WI, USA) to each well. Plates were gently
shaken on a plate shaker for 2min, incubated for an additional
10min at room temperature after which cell viability was evaluated
immediately by luminescence measured with a plate reader
(Wallac 1420 ARVOsx Multilabel Counter; PerkinElmer, Chiba,
Japan). Cell viability of mock-infected cells was designated as
100% viability. Data are presented as the mean±s.d. of three
determinations.
Viral growth in cells
Cells grown in 24-well plates were infected with SIN or reovirus at
an MOI of 0.1. After incubation for 96h, the culture medium was
collected. After freezing and thawing once, the viral titres were
determined by plaque assays using Vero cells.
Western blot analysis
Cells were lysed in buffer (10mM Tris base (pH 8.0), 400mM
NaCl, 3mM MgCl2, 0.5% Nonidet P-40 (Sigma, St Louis, MO,
USA), 100mM phenylmethylsulfonyl fluoride, and 0.01% protease
inhibitor cocktail (Sigma) at 41C for 10min. Protein extracts were
electrophoresed on 10% sodium dodecyl sulphate-polyacrylamide
electrophoresis gels (SDS-PAGE) and transferred to polyvinylidene
fluoride (PVDF) membranes (Bio-Rad, Hercules, CA, USA).
After transfer, the PVDF membranes were washed with 0.1%
Tween 20 in TBS, and incubated with the primary antibody (rabbit
anti-SIN polyclonal antibody, 1:500; Laminin-R (Santa Cruz,
Heidelberg, Germany) 1:5000 overnight at 41C for immunoblot-
ting. Then, PVDF membranes were washed again and incubated
with a 1:2000 dilution of horseradish-peroxidase-conjugated IgG
Envisionþ(Dako, Carpinteria, CA, USA), as a secondary antibody,
for 2h at room temperature. Finally, the membranes were
incubated with enhanced chemiluminescence (ECL)þ horseradish
peroxidase substrate solution included in the ECLþkit
(GE Healthcare UK Ltd, Chalfont St Giles, UK). Protein bands
were visualised by exposing the membrane to Hyperfilm
(GE Healthcare UK Ltd).
Ras activation assay
Confluent cells (70–80%) grown in 10-cm dishes were lysed with
1 Mg
2þ lysis buffer (Ras activation assay kit; Upstate Biotechno-
logy, Lake Placid, NY, USA). To determine the level of activated Ras
(Ras-GTP) in these cells, we incubated 1mg of cell lysate with 10ml
of Raf-1 Ras binding domain agarose conjugate at 41Cf o r3 0 m i n .
The beads were then collected, washed, re-suspended in 2 
Laemmli buffer, and boiled for 5min. This was then followed by
SDS-PAGE and western blotting with an anti-Ras antibody (clone
RAS 10) according to the manufacturer’s instructions. To determine
the level of total Ras, we directly subjected cell lysates to SDS-PAGE
and western blotting with anti-Ras antibody.
Terminal deoxyribonucleotidyl transferase–mediated
dUTP nick-end labelling (TUNEL) assays
A total of 5.0 10
5 cells seeded on Lab-Tek chamber slides (Nalge
Nunc International, Rochester, NY, USA) were incubated in the
presence or absence of SIN at an MOI of 1 for 24h. The cells on
chamber slides were washed twice with PBS, air dried, and fixed
with 4% paraformaldehyde at room temperature for 30min. The
TUNEL assays were carried out by using an in situ apoptosis
detection kit (TaKaRa, Tokyo, Japan) according to the manufac-
turer’s instructions. Cells were viewed and photographed under a
fluorescence microscope (Nikon Inc., Tokyo, Japan).
Real-time RT-PCR analysis of gene expression
Total RNA was isolated from cells using Trizol reagent (Invitrogen,
Carlsbad, CA, USA) according to the manufacturer’s protocol.
Double-stranded cDNA was synthesised from 20mgo ft o t a lR N A
using Ready-to-Go You-Prime first-strand beads (GE Healthcare UK
Ltd) and Oligo(dT) primer (Sigma-Genosys, Ishikari, Japan). Real-
time quantitative RT-PCR was performed with a single method using
a LightCycler FastStart DNA Master SYBR Green 1 Kit (Roche
Diagnostics GmbH, Mannheim, Germany). We chose to assess the
expression of 15 genes (Table 1) related to apoptotic pathways. The
transcript levels of these genes were estimated from the respective
standard curves and normalised to the expression of glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) (forward, 50-CATCTCTGC
CCCCTCTGCTGA-30 and reverse, 50-GGATGACCTTGCCCACAG
CCT-30) transcript levels determined in corresponding samples. The
experiments were carried out in triplicate.
RESULTS
Cytopathic effects (CPEs) of SIN and reovirus
To determine the susceptibility of OSCC to SIN, we carried out cell
viability assays. The OSCC cell lines (HSC-2, HSC-3, HSC-4, SCC-4,
SAT, Ca9-22, SKN-3, KON, HO-1-N1, KOSC-2, OK-92, Sa-3, and
H-1), as well as primary cultured keratinocytes derived from
normal oral tissues, were infected with SIN at an MOI of 20, 1, 0.1,
or 0.01. For comparison, cells were also infected with reovirus at an
MOI of 20. As shown in Figure 1, 96h after SIN infection at an MOI
of 20, strong CPEs were observed in all OSCC cell lines except
HSC-4 (Figure 1). No morphologic change was observed in normal
keratinocytes, whereas reovirus infection caused similar CPEs in
10 cell lines as well as in normal cells. The CPEs were weaker in
three cell lines (SAT, OK-92, Sa-3, HO-N-1), and stronger in
HSC-4. Sindbis virus infection at an MOI of 1, 0.1, or 0.01 also
induced sufficient CPEs in all OSCC cell lines except HSC-4.
Viral growth of SIN in cancer cells
To examine whether the extent of cell cytotoxicity after SIN
infection correlates with viral growth, viral titres in the cancer cell
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Name Forward Reverse
Caspase 3 TGAGCCTGAGCAGAGACATGA CCTTCCTGCGTGGTCCAT
Caspase 7 AAGCTGGGCAAATGCATCAT TGTATGGTCCTCTTCAGAAGCTTTT
Caspase 8 GGTGGCTGCCTGAGGAATAC TCCCAAGGTTCAAGTGACCAA
Caspase 9 CAGTAACCCCGAGCCAGATG TGAGCCCACTGCTCAAAGATG
Caspase 10 AGTGGACAAACAGGGAACAAAGA GGTTATAGCCAATGATTCGTTTGA
Bcl-2 CATGTGTGTGGAGAGCGTCAA GCCGGTTCAGGTACTCAGTCA
Cytochrome c TGGTTGCACTTACACCGGTACT ACGTCCCCACTCTCTAAGTCCAA
Bax TTGCCGTCAAAACATGTCA CCGCCGTGGACACAGACT
FADD CCTGCACAGATATTTCCATTTCTTC GTGGAGTAACAGTGTGACTGCTCAT
PIP1 TGGTACAGGCCAATTCCAAGT TGATGAACTCGTCCCACCAA
TRAF2 TCAGGACCACGTCAAGACTTGT CAGCACCGAGCTCAGTAGCA
NIK GTTCAGCCCCACCTTTTCAG TTTGCTGCGACGCTTTCC
IKK GCAGGCTCTTTCAGGGACAA TCCAAGTCAAGCTGAATGCTTTT
IkBa TCCTGCACTTGGCCATCAT GCAATTTCTGGCTGGTTGG
NF-kB AATGGGCTACACCGAAGCAA GCCGCTGTCGCAGACACT
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Figure 1 Cell viability assays of cells infected with SIN or reovirus. (A) Cells, 1 10
4, were plated and mock-infected or infected with SIN or reovirus at
an MOI of 20 for 96h. The surviving cells were evaluated by using the luminescence with a plate reader. Cell viability of mock-infected cells was designated as
100% viability. (B) Cell viability assays of cells infected with SIN. Cells, 1 10
4, were plated and mock-infected or infected with SIN at the indicated MOI.
The surviving cells were evaluated by luminescence on a plate reader 96h after infection. Cell viability of mock-infected cells was designated as 100% viability.
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High growth of SIN and reovirus was observed in all OSCC cell
lines (Figure 2) whereas no viral growth was observed in normal
keratinocytes, supporting the idea that the cytotoxicity caused by
SIN depends on replication of the virus. However, there was little
correlation between the viral titre and cytotoxicity caused by
infection. For example, the SIN viral growth was high in HSC-4
cells but SIN infection caused little cytotoxicity in these cells. In
contrast, viral growth was low in Sa-3 and H-1 cells but SIN caused
high cytotoxicity in these cell lines.
Expression of SIN protein
To further determine whether the cytotoxicity caused by SIN
infection correlates with SIN replication, the SIN protein synthesis
in cells was analysed 6, 12, 24, and 48h after SIN infection at an
MOI of 1 in HSC-3 and HSC-4 cells. The reason two cell lines were
chosen was that the HSC-4 cells displayed the lowest levels of CPE
and the HSC-3 cells displayed the highest levels of CPE at an MOI
of 20 (Figure 1A). As shown in Figure 3, immunoblot analyses with
anti-SIN antibody showed that SIN protein synthesis in both
HSC-3 and HSC-4 was substantial 12h after SIN infection. High
viral growth and viral protein expression in HSC-4 cells occurred,
but little cytotoxicity was observed after infection with SIN,
suggesting that the cytotoxicity caused by SIN infection is not the
direct result of viral protein synthesis and viral replication.
Ras activities in cancer cells
The GTP-bound, active form of Ras stimulates the downstream
effector, Raf-1 through its binding to the Raf-1-Ras binding
domain. To examine the activation of Ras in cancer cell lines, we
measured the amount of Ras-GTP using Raf-1-Ras binding domain
conjugated to agarose beads (Upstate Biotechnology) to pull down
activated Ras. Lysates were prepared from cells grown to 80%
confluence under normal growth conditions. As shown in
Figure 4A, elevated levels of Ras activity were observed in both
normal human keratinocytes and cancer cell lines except OK-92,
which was shown not to be susceptible to reovirus (Figure 1A).
Apoptosis after reovirus infection is Ras dependent.
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Figure 2 Viral growth (A and B) in cells infected with SIN. (A) Titre of
virus grown in various cells (keratinocytes, HSC-2, HSC-3, SCC-4, SAT,
OK-92, Ca9-22, SKN-3, KON, KOSC-2, Sa-3, H-1, HO-1-N1, and HSC-4)
was measured 96h after SIN infection at an MOI of 0.1. (B) The titre of
virus in cells (keratinocytes, HSC-2, HSC-3, SCC-4, SAT, OK-92, Ca9-22,
SKN-3, KON, KOSC-2, Sa-3, H-1, HO-1-N1, and HSC-4) was measured
96h after reovirus infection at an MOI of 0.1.
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Figure 3 Western blot analysis of SIN proteins, E1 and E2. SIN protein
synthesis in cells was analysed 6, 12, 24, and 48h after SIN infection at an
MOI of 1 in HSC-3 and HSC-4 cells. An arrow indicates the position of the
SIN E1 and E2 proteins.
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Figure 4 (A) The activated Ras protein levels in cancer cell lines
(HSC-3, SCC-4, H-1, OK-92) and normal human keratinocytes
(keratinocytes) were examined. The amount of Ras-GTP was measured
using Raf-1-Ras binding domain conjugated to agarose beads to pull down
activated Ras. This was then followed by SDS-PAGE and western blotting
with an anti-Ras antibody. (B) The expression of 67-kDa laminin receptor
in all cancer cell lines and normal cells was examined using SDS-PAGE and
western blotting with a Laminin-R antibody.
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It has been reported that a 67-kDa laminin receptor, which is
substantially upregulated in numerous cancers, is a major receptor
of SIN in mammalian cells. We examined the expression of the
67-kDa laminin receptor in all cancer cell lines and normal human
keratinocytes. We confirmed that the 67-kDa laminin receptor is
expressed in normal human keratinocytes as well as our cancer cell
lines, except for in HSC-4 cells (Figure 4B).
SIN-induced apoptosis in cancer cell lines
Viral infection often leads to an apoptotic response in infected
cells. To determine whether infection with SIN induces apoptosis
in HSC-3 and HSC-4, we carried out TUNEL assays. We observed
TUNEL-positive cells in HSC-3 cells 24h after SIN infection at an
MOI of 1 (Figure 5). In contrast, few apoptotic cells were observed
in HSC4-cells, indicating that the cytotoxicity of SIN infection
correlates with the apoptosis induced by viral infection, but not
always with the extent of viral replication.
Apoptotic pathway
To determine which apoptotic pathway is induced by SIN, we
examined the expression of mRNAs relating to apoptosis in HSC-3
and HSC-4 cells by quantitative PCR 14, 18, and 22h after SIN
infection at an MOI of 1. Caspases 7, 8, and 10 were upregulated in
both HSC-3 and HSC-4 cells. However, caspases 3 and 9,
cytochrome c, NF-kB, and IKK were remarkably upregulated only
in HSC-3 cells (Figure 6).
DISCUSSION
In this study, we investigated whether SIN causes cytotoxic effects
in OSCC cells. We demonstrated that SIN can induce more cell
death than reovirus at an MOI of 20 in 10 of 13 OSCC cell lines.
Furthermore, all OSCC cell lines, with one exception, were
susceptible to SIN infection at a low MOI. Viral growth assays
with OSCC cell lines indicated that SIN can grow to a high titre,
and that cytotoxicity does not always correlate with the extent of
viral growth and replication. In addition, normal keratinocytes are
not susceptible to SIN, and did not support viral growth and
replication.
Although it has been reported that the specific cytotoxicity
induced by SIN infection in cancer cells was due to the expression
of the 67-kDa laminin receptor on the cell membrane, we
confirmed that normal keratinocytes had the same level of
expression of the 67-kDa laminin receptor as cancer cells, with
the exception of HSC-4. It was suggested that there is a difference
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Figure 5 TUNEL assays of cells infected with SIN. HSC-3 (A–D) and HSC-4 (E–H) were infected with SIN (phase contrast, B and F; TUNEL, D and
H) at an MOI of 1, and without SIN (phase contrast, A and E; TUNEL, C and G).
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with tumour tissues, and that this could provide an explanation for
the natural propensity of SIN towards tumour cells (Hay, 2004).
The discrepancy between the high replication and low expression
of laminin receptors in HSC-4 might be because SIN can use
receptors other than the laminin receptor to enter mammalian
cells. These results could be responsible for the correlation with
cytotoxicity and viral replication in normal human keratinocytes
and OSCC cell lines but not in HSC-4. We next investigated why
replication of SIN in HSC-4 induced little cytotoxicity. Reovirus is
a novel oncolytic agent for cancer therapy based on its targeting of
the activated Ras signalling pathway. Roughly 50% of all cancers
have an activated Ras signalling pathway because of activating
mutations in the ras gene itself, and of genes for proteins that act
up- or downstream of ras. Therefore, we evaluated whether the
oncolytic potency of SIN in oral cancer cells depends on increased
Ras activity in these cells. In cancer cells including HSC-4, ras
activation was correlated with the CPE of reovirus, but not SIN. In
particular, OK-92 had a strong CPE after SIN infection, but Ras
activation was very weak in this cell line. A number of studies
suggest that apoptosis is important in viral CPEs and the
mechanism of SIN-induced apoptosis may be related to members
of the caspase family and Bcl-2 proteins (Nava et al, 1998;
Kerr et al, 2002). Our study showed that cell death in HSC-3 cells,
the most susceptible of the cell lines to SIN, was induced by
apoptosis. Therefore, we investigated which apoptotic pathway was
activated in HSC-3 and HSC-4 cells and compared the levels of
gene expression of all known apoptotic mediators. In HSC-3 cells,
members of the caspase family, cytochrome c, and IkBa were
upregulated, indicating that SIN causes oncolysis by activating
several apoptotic pathways. The upregulation of Bcl-2 and NF-kB,
known anti-apoptotic factors which may be involved in cell
survival, was not observed in HSC-4 cells. Consequently, these
findings suggest that another mechanism that inhibits cell death
may be activated in HSC-4 cells.
The observation that SIN could replicate but could not induce
apoptosis in the HSC-4 cell line suggests that the link between
apoptosis and viral replication does not exist in these cells.
Vertebrate cell death caused by SIN infection was shown to be
caused by apoptosis and resulted in a lytic infection. In contrast,
all invertebrate cells tested to date survive infection, with some
cultures displaying varying degrees of CPE and becoming
persistently infected for long periods of time (Karpf et al, 1997).
Viral growth in invertebrates has been studied in various species of
mosquitoes (Greene et al, 2005; Mudiganti et al, 2006). Inverte-
brate cells are known to differ from mammalian cells during SIN
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Figure 6 Expression of apoptosis-related genes after SIN infection. The expression of mRNAs related to apoptosis in (A) HSC-3 and (B) HSC-4 cells
was measured in triplicate using quantitative PCR 6, 12, and 18h after SIN infection at an MOI of 1. All bars represent average values±standard deviation
from triplicate samples, which were normalised to GAPDH expression.
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causing apoptosis (Miller and Brown, 1992), but the processes
involved are not clearly understood. Given that HSC-4 cells showed
only slight CPEs during the acute phase of infection, as was
observed in invertebrate cells (data not shown), the same
mechanism may be involved in HSC-4 cells. Our study suggests
that an apoptotic pathway, possibly related to caspases 3 and 9,
cytochrome c, NF-kB, IkBa, and IKK, might be involved in the
cytotoxicity caused by SIN infection.
The most favourable feature of SIN is that it can attach and enter
all OSCC cell lines but not normal keratinocytes, a characteristic
that would be useful for gene therapy in oral cancer. The goal of
cancer gene therapy is to introduce new genetic material into
target cells without damaging normal tissues. Viruses commonly
used in oral cancer gene therapies include retroviruses and
adenoviruses. Transduction studies have demonstrated that direct
injection, but not topical application, of adenoviral constructs can
transduce genes into oral cancer cells in vivo (Clayman et al, 1995).
These therapies are limited by safety and targeting to tumours.
Targeting is a key determinant of the safety of viral vectors. As
the dose of a viral vector increases, improvement may be seen, but
side effects can also increase. Therefore, an effective, low-dose
treatment is necessary to target cancer cells. Recently, a replica-
tion-defective SIN viral vector was developed as a gene therapy
vector for transient and high-level expression of heterologous
genes (Tseng et al, 2004). However, replication-competent wild-
type SIN has an additional favourable feature for a modality of
cancer therapy (Unno et al, 2005). Replication-competent onco-
lytic viruses, like SIN used in this study, would not follow a simple
dose–response curve. Theoretically, a single viable virus particle
could potentially kill an entire tumour if it replicates and spreads
efficiently throughout the tumour mass.
In conclusion, SIN appears to be a feasible therapeutic modality
for targeting oral cancer cells. With further work, SIN could be a
useful oncolytic viral therapy in oral cancers.
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